Recombinant Proteins 

   

Protein Name

Origin of gene

Pack Size

Cat.#

Price

gB 11-67 aa

C M V

0.2 mg

Q3285

£250

Pp28 (UL99) 130-160 aa

C M V

0.2 mg

Q3281

£250

Pp150 (UL32) 1011-1048 aa

C M V

0.2 mg

Q3283

£250

Pp65 (UL83) 297-510 aa

C M V

0.2 mg

Q3287

£250

Pp52(UL44) 202-434 aa

C M V

0.2 mg

Q3289

£250

Pp38 (UL80a) 117-373 aa

C M V

0.2 mg

Q3291

£250

gE protein 19-153 aa

Tick-born Encephalitis Virus

0.2 mg

Q3351

£250

HAV VP1-P2A 722-830aa 

Hepatitis A Virus

0.2 mg

Q3121

£250

HAV VP4-VP2 55-164aa 

Hepatitis A Virus

0.2 mg

Q3123

£250

HAV P2C-P3A 1492-1606aa 

Hepatitis A Virus

0.2 mg

Q3125

£250

HAV P3C 1643-1743aa 

Hepatitis A Virus

0.2 mg

Q3127

£250

HAV VP3 304-415aa 

Hepatitis A Virus

0.2 mg

Q3129

£250

HAV VP1-P2A 669-782aa 

Hepatitis A Virus

0.2 mg

Q3131

£250

HAV HAV P2C 1121-1234aa 

Hepatitis A Virus

0.2 mg

Q3133

£250

HAV P2C-P3A 1392-1521aa 

Hepatitis A Virus

0.2 mg

Q3135

£250

HBV core protein 

Hepatitis B Virus

0.2 mg

Q3141

£250

HBeAg protein

Hepatitis B Virus

0.2 mg

Q3143

£250

HCV core 2-119aa (genotype 1a)

Hepatitis C Virus

0.2 mg

Q3151

£120

HCV core 2-119aa (genotype 1b)

Hepatitis C Virus

0.2 mg

Q3153

£120

HCV core 2-119aa (genotype 2a)

Hepatitis C Virus

0.2 mg

Q3155

£120

HCV core 2-119aa (genotype 2b)

Hepatitis C Virus

0.2 mg

Q3157

£120

HCV core 2-119aa (genotype 3a)

Hepatitis C Virus

0.2 mg

Q3159

£120

HCV core 2-119aa (genotype 3b)

Hepatitis C Virus

0.2 mg

Q3161

£120

HCV core 2-119aa (genotype 3/10)

Hepatitis C Virus

0.2 mg

Q3163

£120

HCV core 2-119aa (genotype 4)

Hepatitis C Virus

0.2 mg

Q3165

£120

HCV core 2-119aa (genotype 5)

Hepatitis C Virus

0.2 mg

Q3167

£120

HCV core 2-119aa (genotype 6a)

Hepatitis C Virus

0.2 mg

Q3169

£120

HCV core 24 

Hepatitis C Virus

0.2 mg

Q3171

£120

HCV core 105-302 aa

Hepatitis C Virus

0.2 mg

Q3173

£120

HCV NS3 1192-1456aa (genotype 1a) 

Hepatitis C Virus

0.2 mg

Q3175

£120

HCV NS3 1192-1456aa (genotype 1b) 

Hepatitis C Virus

0.2 mg

Q3177

£120

HCV NS3 1192-1456aa (genotype 2b) 

Hepatitis C Virus

0.2 mg

Q3179

£120

HCV NS3 1192-1456aa (genotype 2c) 

Hepatitis C Virus

0.2 mg

Q3181

£120

HCV NS3 1192-1456aa (genotype 5) 

Hepatitis C Virus

0.2 mg

Q3183

£120

HCV NS3 1192-1456aa (genotype 6a) 

Hepatitis C Virus

0.2 mg

Q3185

£120

HCV NS3 1359-1456aa (genotype 1a) 

Hepatitis C Virus

0.2 mg

Q3187

£120

HCV NS3 1359-1456aa (genotype 1b) 

Hepatitis C Virus

0.2 mg

Q3189

£120

HCV NS3 1359-1456aa (genotype 2b) 

Hepatitis C Virus

0.2 mg

Q3191

£120

HCV NS3 1359-1456aa (genotype 2c) 

Hepatitis C Virus

0.2 mg

Q3193

£120

HCV NS3 1359-1456aa (genotype 3) 

Hepatitis C Virus

0.2 mg

Q3195

£120

HCV NS3 1359-1456aa (genotype 4) 

Hepatitis C Virus

0.2 mg

Q3197

£120

HCV NS3 1359-1456aa (genotype 5) 

Hepatitis C Virus

0.2 mg

Q3199

£120

HCV NS3 1359-1456aa (genotype 6) 

Hepatitis C Virus

0.2 mg

Q3201

£120

HCV NS4 artificial mosaic protein (1691-1710aa, 1712-1733aa, 1921-1940aa, from 1,2,3.5 genotypes)

 Hepatitis C Virus

 0.2 mg

 Q3203

 £200

HCV NS4 1916-1947aa 

Hepatitis C Virus

0.2 mg

Q3205

£120

HCV NS5 2061-2302aa 

Hepatitis C Virus

0.2 mg

Q3207

£120

HCV NS5 2212-2313aa (genotype 1a) 

Hepatitis C Virus

0.2 mg

Q3209

£120

HCV NS5 2212-2313aa (genotype 1b) 

Hepatitis C Virus

0.2 mg

Q3211

£120

HCV NS5 2212-2313aa (genotype 2a) 

Hepatitis C Virus

0.2 mg

Q3213

£120

HCV NS5 2212-2313aa (genotype 2b) 

Hepatitis C Virus

0.2 mg

Q3215

£120

HCV NS5 2212-2313aa (genotype 3a) 

Hepatitis C Virus

0.2 mg

Q3217

£120

HCV NS5 2212-2313aa (genotype 3b) 

Hepatitis C Virus

0.2 mg

Q3219

£120

HCV NS5 2212-2313aa (genotype 4) 

Hepatitis C Virus

0.2 mg

Q3221

£120

HCV NS5 2212-2313aa (genotype 5) 

Hepatitis C Virus

0.2 mg

Q3223

£120

HCV NS5 2212-2313aa (genotype 6a) 

Hepatitis C Virus

0.2 mg

Q3225

£120

HDV Ag

Hepatitis D Virus

0.2 mg

Q3227

£250

HEV mosaic protein contains 12 HEV immunodominant regions from ORF2 and ORF3

Hepatitis E Virus

0.2 mg

Q3231

£250

HEV ORF2 452-617aa

Hepatitis E Virus

0.2 mg

Q3233

£250

HEV mosaic protein contains 4 HEV immunodominant regions from ORF2 and ORF3

Hepatitis E Virus

0.2 mg

Q3235

£250

HHV-4 p18 1-119aa

Epstain-Barr Virus

0.2 mg

Q3341

£250

HHV-4 p23 1-162aa

Epstain-Barr Virus

0.2 mg

Q3343

£250

HHV-4 mosaic protein EBNA1 (1-90/408-498aa)

Epstain-Barr Virus

0.2 mg

Q3345

£350

HHV-4 EA 306-390aa

Epstain-Barr Virus

0.2 mg

Q3347

£250

HIV-1 p17/24/gp120-gp41 

H I V

0.2 mg

Q3241

£120

HIV-1 p17/24/gp120 

H I V

0.2 mg

Q3243

£120

HIV-1 gp41 

H I V

0.2 mg

Q3245

£120

HIV-1 p17-p24 

H I V

0.2 mg

Q3247

£120

HIV-2 gp32 

H I V

0.2 mg

Q3249

£120

HIV-1 p24 

H I V

0.2 mg

Q3251

£120

HIV 1,2 envelope, conjugated. Specifity - HIV-1,2 envelope antibodies

H I V

0.2 mg

Q3253

£350

HIV 1 envelope. Specifity - HIV-1 and HIV-O antibodies

H I V

0.2 mg

Q3255

£250

HIV 1 p24 core. Specifity - HIV-1 antibodies

H I V

0.2 mg

Q3257

£250

HIV type O envelope. Synthetic HIV type-O peptide. Specifity - HIV-Type O antibodies

H I V

0.2 mg

Q3259

£250

HIV 2 gp32 envelope.Specifity - HIV-2 antibodies

H I V

0.2 mg

Q3261

£250

HIV 2 gp36 envelope. Synthetic HIV-2 Peptide. Specifity - HIV-2 antibodies.

H I V

0.2 mg

Q3263

£250

HLTV-I envelope. Specifity - HTLV-I/II envelope antibodies

Human Lymphotropic Virus

0.2 mg

Q3311

£250

HLTV-I p24 core. Specifity - HTLV-I core antibodies

Human Lymphotropic Virus

0.2 mg

Q3313

£250

HLTV-I virus mosaic protein contains the gp21/gp46 374-400/190-207aa)

Human Lymphotropic Virus

0.2 mg

Q3315

£350

HSV-1 gD 266-394aa

H S V

0.2 mg

Q3271

£250

HSV-2 gD 266-394aa

H S V

0.2 mg

Q3273

£250

HSV-2 qG 525-578aa

H S V

0.2 mg

Q3275

£250

HSV-1 gG 84-175aa

H S V

0.2 mg

Q3277

£250

Mosaic protein TmpA (P41: 23-41aa, 288-325)

Treponema pallidum

0.2 mg

Q3104

£350

P17

Treponema pallidum

0.2 mg

Q3101

£250

P41

Treponema pallidum

0.2 mg

Q3102

£250

P47

Treponema pallidum

0.2 mg

Q3103

£250

P24 (GRA1) 57-149 aa

Toxoplasma gondii

0.2 mg

Q3113

£250

P29 (GRA7) 24-100 aa

Toxoplasma gondii

0.2 mg

Q3115

£250

P30 (SAG1) 45-198 aa

Toxoplasma gondii

0.2 mg

Q3117

£250

MIC 3 protein 234-306 aa

Toxoplasma gondii

0.2 mg

Q3111

£250

Rubellavirus E1 regions 157-176/374-390/213-239aa

Rubella Virus

0.2 mg

Q3361

£350

Rubellavirus E2 regions 31-105aa

Rubella Virus

0.2 mg

Q3363

£250

Rubellavirus C regions 1-123aa

Rubella Virus

0.2 mg

Q3365

£250

SARS-Associated Coronavirus E recombinant protein 

SARS

0.2 mg

Q3321

£350

SARS-Associated Coronavirus Nucleocapsid recombinant protein N 

SARS

0.2 mg

Q3323

£350

SARS-Associated Coronavirus Nucleocapsid recombinant protein C 

SARS

0.2 mg

Q3325

£350

SARS-Associated Coronavirus M recombinant protein 

SARS

0.2 mg

Q3327

£350

SARS-Associated Coronavirus Spike mosaic recombinant protein S(N) 

SARS

0.2 mg

Q3329

£350

SARS-Associated Coronavirus Spike mosaic recombinant protein S(M) 408-470/540-573aa

SARS

0.2 mg

Q3331

£350

SARS-Associated Coronavirus Spike mosaic recombinant protein S(C) 

SARS

0.2 mg

Q3333

£350

VZV gE 48-135aa

Varicella Zoster Virus

0.2 mg

Q3301

£250

VZV ORF9 (6-28aa)+(76-100aa)

Varicella Zoster Virus

0.2 mg

Q3303

£250

VZV ORF26 (9-33aa)+(184-208aa)

Varicella Zoster Virus

0.2 mg

Q3305

£250

 

 

 

 

 

Cytokines

 

 

 

 

Erythropoietin, EPO

human

0.1 mg 

Q4001

 £150

Interferon- α 2b, IFN-α 2 (IFN- α2b)

human

 0.1 mg 

Q4003

 £150

Interferon- γ, IFN- γ

human

 0.1 mg 

Q4005

 £150

Interleukin-1 α, IL-1α

human

 0.1 mg 

Q4007

 £250

Interleukin-1 Receptor antagonist, IL-1Ra

human

 0.1 mg 

Q4011

 £250


                                                    Yorkshire Bioscience Ltd, Biocentre, York Science Park, Heslington, York YO10 5NY, UK
                                                    Tel: +44 (0)1904561592 Fax +44 (0)1904567621 General Information: info@york-bio.com
                                                                                Copyright © 2004-2006 Yorkshire Bioscience Ltd.